Genmab — Marts 2017
-
in NICE website as previous link didnt work
https://www.nice.org.uk/guidance/indevelopment/gid-ta10076/documents -
"
This is not the only appraisal in the pipeline for daratumumab. NICE is also currently considering a separate appraisal looking at daratumumab in combination with established myeloma drugs – lenalidomide (Revlimid
) or bortezomib (Velcade) for relapsed and/or refractory myeloma." https://www.myeloma.org.uk/blog/news/nice-issue-draft-no-on-daratumumab-monotherapy/#1489748505348-01faf5c2-9725 -
Har desværre ikke selv adgang til hele artiklen. http://medwatch.dk/secure/Medicinal___Biotek/article9439445.ece
-
Måske dette har noget med NICE ageren på Dara at gøre. Det lyder sandsynligt. http://medwatch.dk/Medicinal___Biotek/article9436919.ece
-
-
betyder vel ikke det store? NICE prøver vel bare at presse prisen ned, da Darzalex jo er en dyr behandling
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind